COPD Trial, Recruiting NCT07112235 Sponsor: Imperial College London Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07112235
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have COPD:

  • You are a man or woman aged between 40 and 75 years old
  • You have been diagnosed with COPD or have a medical history of it
  • You have smoked at least 20 pack years (roughly 1 pack a day for 20 years, or equivalent), and use of e-cigarettes/vapes is also allowed
  • Your breathing test results show moderate COPD (specific lung function measurements fall within a certain range — confirm with trial site)
  • Your COPD symptoms noticeably get worse when you catch a cold
  • Your COPD has been stable with no flare-ups in the past 8 weeks
  • You are allowed to use short- and long-acting inhaler medicines for your breathing
  • You may have a history of asthma, hay fever, or seasonal allergies, as long as these have not been active in the past 8 weeks
  • You do not have any other significant lung conditions besides COPD, asthma, or allergic rhinitis
  • Having a positive allergy skin test is allowed

If you are a non-smoking control (comparison group without COPD):

  • You are a man or woman aged between 40 and 75 years old
  • You have not been diagnosed with COPD
  • You have smoked fewer than 5 pack years total, and have not smoked or used e-cigarettes/vapes in the past year
  • Your breathing test results are within the normal range (confirm with trial site)
  • You may have a history of asthma, hay fever, or seasonal allergies, as long as these have not been active in the past 8 weeks
  • You do not have any other significant lung conditions besides asthma or allergic rhinitis
  • Having a positive allergy skin test is allowed

If you are a smoking control (comparison group without COPD but with a smoking history):

  • You meet all the same criteria as the non-smoking control group above, except you have smoked at least 20 pack years, and use of e-cigarettes/vapes is also allowed

Who may not be able to join:

  • You have another lung condition that limits airflow, such as bronchiectasis, cystic fibrosis, a collapsed or scarred airway, lung cancer, tuberculosis (TB), or pulmonary fibrosis
  • You have a significant ongoing health condition (such as a heart, liver, kidney, neurological, blood, or mental health condition) that the trial doctor believes could put you at risk or affect the results
  • You are pregnant, planning to become pregnant, breastfeeding, or tested positive for pregnancy at the screening visit
  • You have used steroid medicines (by mouth, inhaler, or nasal spray) in the past 8 weeks
  • You have taken antibiotics in the past 8 weeks
  • You are currently taking nasal medicines, anti-leukotriene medicines, or antihistamines
  • A blood test at your screening visit shows you already have a high level of antibodies to a specific cold virus used in the trial (confirm with trial site)
  • You live with or regularly spend time around babies under 6 months old, very elderly or frail people, pregnant or breastfeeding women, or people with weakened immune systems (such as those with HIV, transplant recipients, or people receiving chemotherapy or immunotherapy)
  • You are already taking part in another clinical trial that the trial doctor believes could make participation risky, affect results, or create too many appointments for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sebastian L Johnston, Imperial College London

Phone: +44 20 7594 8495

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 October 2025
Est. completion
31 March 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Lower Respiratory Symptom Score (LRSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov